Table 1 Descriptive statistics demonstrate patient characteristics and outcomes of MIAMBE technique in the selected studies
Study | Patients | Age (years) | N of sinus augmentation | Sinus augmentation success rate % | Baseline bone height (mm) | Bone gain (mm) | Antral membrane elevation (mm) | Total bone height (mm) | Inflate balloon volume | Type of graft | Membrane perforation | Test for membrane perforation | Complications | Follow-up period after operation | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | M:F | R | M | N | PR % | ||||||||||||
Kfir et al. [5] | 12 | NM | 42 ± 9 | NM | 91.6 | 3.7 ± 1.4 | NM | > 10 | 10–17 | ≤ 2.5 mL | -PRF -ABP -Bi-Ostetic synthetic bone graft | 1 | 8.33 | Valsalva maneuver Direct visualization | 1 membrane tear 1 balloon rupture 1 implant failed | 23 months | |
12 | NM | NM | 100 | 3.5 ± 1.3 | NM | > 10 | 10–18 | 0 | 0 | 1 mild periprocedural nosebleed | 12 months | ||||||
Kfir et al. [29] | 36 | M = 18 F: 18 | 42 ± 9 | 36 | 97.2 | 3.4 ± 2.1 | NM | > 10 | 8–18 | NM | -PRF -ABP -Bi-Ostetic Synthetic bone graft -Fisiograft gel | 1 | 2.77 | Valsalva maneuver | 1 membrane tear 2 implant failed | 6–8 months | |
Hu et al. [30] | 28 | M = 143 F = 14 | 40.2 ± 12.35 | 28 | 92.85 | 4.92 ± 1.24 | NM | Mean 10.9 ± 2.06 | NM | 0.67 ± 0.17 mL | -PRF -Bio-Oss | 2 | 7.14 | Valsalva maneuver | 1 mild nosebleed after surgery 2 membrane tear and the cases aborted | 15.9 ± 2.94 months. | |
Kfir et al. [31] | 112 | M = 50 F = 62 | 44.1 ± 12.9 | NM | 97.3% initial procedural success 100% secondary procedural success | 3.8 ± 2.1 | NM | > 10 | 11–18 | NM | -PRF -Synthetic bone graft -ABP -Fisiograft gel | 12 | 10.71 | Valsalva maneuver Direct visualization | 1 infection and oroantral fistula at 4 weeks 3 membrane tear and the procedures aborted 9 micropuncture | 13 months | |
Mazor et al. [32] | 20 | NM | 37–72 | 24 | 100 | 2–6 | NM | 11 | NM | NM | -PRF -Synthetic bone substitute | 0 | 0 | Valsalva maneuver Direct visualization | 1 patient was allergic to the antibiotic | 18 months | |
Petruzzi et al. [33] | 40 | M = 16 F = 24 | 41.5 | NM | NM | 8.00 ± 2.19 | 0.6 | ≤ 20 | 14.66 ± 1.48 | 1– ml | Calcium sulphate solution | 3 | 7.5 | Microscope (KarlKaps) | 1 m acrolaceration 2 m icrolacerations 4 hemifacial edema | 1 year | |
Peñarrocha-Diago et al. [34] | 6 | M = 5 | 27–51 | 6 | 83.3% for the all 6 cases 100% for the five cases | 2.1–4.1 | 7.2–10.8 | 8.7 | NM | 11.3–14.5 | NM | -ABP -BIO-OSS bovine bone grafts | 1 | 16.66 | (Medi Pack Pal) endoscope | 1 membrane tear and case aborted | 1 year after prosthetic loading |
Gonzalez et al. [35] | 14 | M = 7 F = 7 | NM | NM | 71.4 | 5.2 | 8.5 | NM | NM | NM | BIO-OSS bovine bone grafts | 3 | 21.32 | An operating microscope | Failure of four cases due to mucosa perforation (21.32%) and balloon breakage (7.14%). 1 implant showed marginal periimplantitis which treated successfully | 1 year | |
Dhandapani et al. [36] | 9 | NM | 25–60 | 10 | 100 | 5–8 | 3–5.5 | 4.34 | ≥ 10 | 13.5–9 | 1 cc | Irradiated allogeneic cancellous bone and marrow graft | 0 | 0 | NM | No complications | 6 months |
Asmael, and Lateef [37] | 13 | M = 4 F:9 | 28–57 | 17 | 100 | 2.3–7.8 | 4.9 –10.6 | 6.70 | NM | 9.8–17.2 | 0.5–1 cc | Particulate bone grafts (βTricalcium Phosphate) | 0 | 0 | Direct vi ion Hydraulic pressure | 1 mild nasal bleeding 1 infraorbital ecchymosis | 1 year |
Total : Average Total : Range | 91.6 100–71.4% | 6.968 3–10.8 mm | 6.76 0–21.32% | ||||||||||||||